Synbitide HFA MDI (budesonide/procaterol) / Intech Biopharm  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synbitide HFA MDI (budesonide/procaterol) / Intech Biopharm
NCT02165046: Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.

Completed
1
24
RoW
Budesonide, Procaterol
Intech Biopharm Ltd.
Asthma, Chronic Obstructive Pulmonary Disease (COPD)
04/12
08/12
NCT02165033: Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

Completed
1
16
RoW
Budesonide/Procaterol 180/10 X 4 puffs, SYN006 HFA MDI
Intech Biopharm Ltd.
Asthma
01/13
02/13

Download Options